Exhibit 231 · Public inquiry report
Infected Blood Inquiry: Volume 3, What Happened and Why?
Competitive mass production led to commercial products being manufactured in the US and in Europe from pools which consisted of several thousand individual donations (“large pool concentrates”).
Examines contemporaneous knowledge of infection risks and the increase in plasma pool sizes used for factor concentrates.
- Source
- Infected Blood Inquiry, Sir Brian Langstaff
- Date
- 20 May 2024
- Quoted from
- Volume 3, early chapter on blood products (PDF p. 43)
- Grade
- Primary record
- Document
- https://www.infectedbloodinquiry.org.uk/sites/default/files/Volume_3.pdf
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit
- Note
- Chapters 3.5–3.8 and 3.15; especially printed pp. 458–466.